Insights

August 27, 2024

What to know about Stiff Person Syndrome, a rare autoimmune condition

There are over 7,000 rare diseases that affect very small numbers of patients around the world. Due to the rarity of these conditions, it can be difficult to conduct the research needed to better understand them and to develop effective treatments. One rare disease that has recently come into the spotlight is called Stiff Person Syndrome (SPS). In 2022, global superstar Celine Dion revealed that she had been diagnosed with SPS, which had caused her to stop performing. This year, she released a documentary shedding light on her struggles with SPS symptoms and raising awareness. Read now

August 15, 2024

How precision medicine and a life-saving clinical trial turned a grim prognosis into a cancer-free diagnosis

When Peter*, an adventurous 60-year-old, was diagnosed with stage 2 esophageal cancer, he underwent standard treatment with chemotherapy, radiation, and surgery, and hoped that cancer was behind him. Unfortunately, his cancer recurred just five months later. Over the next three years, as his cancer spread to his liver and lungs. In the face of a grim prognosis, Peter’s refusal to give up led him to Private Health Management (PHM). Read now

August 15, 2024

Navigating Cancer Care: PHM’s Expertise in Clinical Trials

Clinical trials are pivotal in cancer treatment innovation, offering new hope and possibilities for patients. At Private Health Management (PHM), we understand that the decision to participate in a clinical trial can be daunting. Our team of experienced research scientists, clinicians, and care coordinators provide expert, independent advice tailored to each patient’s individual needs and care goals. By demystifying the process and highlighting the potential benefits, we strive to make clinical trials a viable and accessible option for patients who can benefit the most. Read now

August 15, 2024

New blood tests may help diagnose Alzheimer’s disease faster and more accurately

Alzheimer’s disease affects more than 6 million Americans and is the leading cause of dementia, but it can be challenging to correctly diagnose. Results of a new study suggest that a simple blood test may be able to quickly and accurately improve Alzheimer’s diagnosis. Private Health Management (PHM) is committed to providing our clients with Alzheimer’s with the most advanced care and we have helped them receive this useful test. Explore key takeaways from this promising study. Read now

August 15, 2024

Highlighting the latest in cancer research

Each June, over 40,000 oncology professionals, including physicians, researchers, patient advocates, and pharmaceutical representatives attend the American Society of Clinical Oncology (ASCO) meeting in Chicago, IL. This meeting is considered the premiere forum for the presentation of the most recent scientific progress made in cancer research. Private Heath Management’s research scientists attend dozens of presentations each year to stay current on the latest clinical data and emerging technologies. Here are some of the most exciting developments from ASCO 2024. Read now

August 07, 2024

FDA approves first blood test to detect colorectal cancer

On July 29, the U.S. Food and Drug Administration (FDA) approved Guardant Health’s Shield™ test, the first colorectal cancer screening test that analyzes a blood sample to identify molecular signs of cancer. The latest research shows that early detection of cancer improves treatment outcomes and survival rates and experts predict that having a non-invasive option will help to screen more patients and catch colorectal cancer at treatable stages. Read now

July 30, 2024

Innovative Captive Strategies Partners with Private Health Management to Support Members with Serious and Complex Medical Conditions

Private Health Management ("PHM"), a clinically sophisticated complex care management firm, is excited to announce it has been selected by Innovative Captive Strategies ("ICS"), a leading provider of captive insurance solutions, to deliver comprehensive care support to ICS's clients and their plan members. Read now

July 11, 2024

Private Health Management Advocates for Better Use of Clinical Trials

Private Health Management ("PHM"), a clinically sophisticated complex care management firm, announces the release of its whitepaper, "The Importance of Clinical Trials in Cancer Care." This report highlights the critical role of clinical trials in advancing cancer treatment, improving patient outcomes, and lowering costs for employers. Read now

July 11, 2024

The Importance of Clinical Trials in Cancer Care

Clinical trials are pivotal in advancing cancer treatment and improving patient outcomes. They offer patients access to cutting-edge treatments while contributing valuable insights that drive the evolution of cancer care. This whitepaper examines clinical trials as a potential value lever within employer-sponsored health plans, highlighting their dual impact on enhancing cancer care and managing healthcare costs. Read now

June 12, 2024

Navigating a diagnosis with a rare form of Alzheimer’s

Facing a diagnosis of Alzheimer's disease at a young age can be shocking and frightening for patients and their families. James*, an active 50-year-old executive, began experiencing memory lapses, such as forgetting co-workers’ names and simple addresses. Seeking further assistance, James turned to PHM upon a family member's recommendation. Read now

June 12, 2024

Protecting yourself from tick-borne illnesses

During the warm months of spring and summer, the looming threat of ticks becomes more palpable. While most people are aware of Lyme disease as the primary concern, ticks carry a staggering array of 13 other diseases. Read now